Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-19

Clinical Trial Update: Broccoli Sprout Extracts Trial to See if NRF2 is Enhanced by Sulforaphane Treatment in Patients With COPD [Phase 2]

View source ↗

Summary

A Phase 2 study investigated whether sulforaphane from broccoli sprout extracts can enhance NRF2 activity in patients with COPD; the trial is completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Broccoli Sprout Extracts
  • Sulforaphane (sulforaphane)

Snippet

Sponsor: Johns Hopkins University | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2017-05-19